Poop pills may stop brain fog in liver patients
NCT ID NCT07454408
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a fecal microbiota transplant (FMT) from healthy donors can prevent severe confusion (hepatic encephalopathy) in 40 patients who still get episodes despite standard drugs after a liver shunt procedure (TIPS). Participants receive either FMT or a placebo, and researchers track safety, recurrence rates, and quality of life. The goal is to find a new option for those not helped by current treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xi'an International Medical Center Hospital
Xi’an, Shanxi, 710100, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Heart scans could flag Who's at risk after liver shunt
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Can tracking hospital care for liver patients reduce repeat admissions?
- Could a fecal transplant stop dangerous brain fog after liver surgery?
- Could poop transplants save sepsis patients?